QSAR Strategy and Experimental Validation for the Development of a GPCR Focused Library
暂无分享,去创建一个
Dragos Horvath | Rafael Gozalbes | Catherine Rolland | Eric Nicolaï | Marie-France Paugam | Laurent Coussy | Frédérique Barbosa | Boryeu Mao | Frédéric Revah | Nicolas Froloff | D. Horvath | R. Gozalbes | N. Froloff | Catherine Rolland | E. Nicolaï | Marie-France Paugam | L. Coussy | F. Barbosa | F. Revah | Boryeu Mao
[1] Gerhard Klebe,et al. Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening. , 2004, Angewandte Chemie.
[2] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to In Vitro Activity Spaces-A Benchmark for Neighborhood Behavior Assessment of Different in Silico Similarity Metrics , 2003, J. Chem. Inf. Comput. Sci..
[3] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[4] A. Good,et al. 3-D pharmacophores in drug discovery. , 2001, Current pharmaceutical design.
[5] D J Diller,et al. The different strategies for designing GPCR and kinase targeted libraries. , 2004, Combinatorial chemistry & high throughput screening.
[6] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[7] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..
[8] Robert D Clark,et al. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.
[9] Dragos Horvath,et al. Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.
[10] Didier Rognan,et al. Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.
[11] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[12] D. Horvath,et al. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation. , 2005, Journal of medicinal chemistry.
[13] A. Methner,et al. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands , 2002, Genome Biology.
[14] Roland E Dolle,et al. Comprehensive survey of combinatorial library synthesis: 2002. , 2003, Journal of combinatorial chemistry.
[15] Robert P Bywater,et al. Recognition of privileged structures by G-protein coupled receptors. , 2004, Journal of medicinal chemistry.
[16] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[17] Bernard Maigret,et al. Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? , 2003, Trends in pharmacological sciences.
[18] T. Klabunde,et al. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. , 2002, Journal of medicinal chemistry.
[19] G. Schneider,et al. Integrating Virtual Screening Methods to the Quest for Novel Membrane Protein Ligands , 2001 .